- 24 h
- 7 Tage
- 14 Tage
- 6 Monate
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17:10 | Cardinal Health to Report Q2 Earnings: What's in Store for the Stock? | 2 | Zacks | ||
| 16:54 | Brightspring Health stock hits all-time high at $81.03 | 1 | Investing.com | ||
| 16:53 | Ondine Biomedical gets $4m investment from HCA Healthcare subsidiary | 2 | Sharecast | ||
| 16:42 | Veru Shares Tumble Despite Enobosarm's Lean Muscle Preservation Breakthrough | 16 | Benzinga.com | ||
| 16:29 | Stereotaxis Hikes on Winning European Approval | 1 | Baystreet.ca | ||
| 16:15 | Glaukos (NYSE:GKOS) Earns "Overweight" Rating from Piper Sandler | 1 | MarketBeat | ||
| 15:50 | EUROEYES (01846): VOLUNTARY ANNOUNCEMENT - THE TOTAL NUMBER OF EYE SURGERIES FOR THE FOURTH QUARTER OF 2024 AND THE YEAR ENDED 31 DECEMBER 2024 | 2 | HKEx | ||
| 15:42 | Veru down 46% despite data for drug preserving lean body mass in Wegovy users | 33 | Seeking Alpha | ||
| 15:42 | Brightspring Health stock soars to all-time high of $22.97 | 1 | Investing.com | ||
| 15:39 | HUMANA AB: Invitation to presentation of Humana's report on the fourth quarter and full year 2024 | 1 | Cision News | ||
| 15:38 | Intuitive Surgical: Roboter-Pionier nach Rally unter Druck - Grund zur Sorge? | 169 | Der Aktionär | Die neue Handelswoche schüttelt die Anleger kräftig durch, nachdem der neue KI-Chatbot aus China insbesondere die US-Tech-Titel massiv unter Druck gesetzt hat. Kurz vor dem Handelsstart an den US-Börsen... ► Artikel lesen | |
| 15:36 | PetVivo Holdings, Inc.: PetVivo Engages Former Dechra North American President, Mike Eldred as Commercial and Operations Advisor | 1 | GlobeNewswire (USA) | ||
| 15:31 | Straumann Holding AG: Einladung: Straumann Group Webcast - Jahresergebnisse 2024 | 134 | EQS Group (DE) | Straumann Holding AG
/ Schlagwort(e): Quartalsergebnis/Vertriebsergebnis
Einladung: Straumann Group Webcast - Jahresergebnisse 2024
27.01.2025 / 15:27 CET/CEST
Datum:... ► Artikel lesen | |
| 15:31 | Straumann Holding AG: Invitation to Straumann Group's FYR 2024 analysts and media conference at Straumann Group Headquarters | 116 | EQS Group (EN) | Straumann Holding AG
/ Key word(s): Quarter Results/Sales Result
Invitation to Straumann Group's FYR 2024 analysts and media conference at Straumann Group Headquarters
27.01.2025... ► Artikel lesen | |
| 15:26 | Veru's drug conserves muscle mass for older patients taking Novo's Wegovy in phase 2 trial | 31 | FierceBiotech | ||
| 15:09 | ORIOLA OYJ: Oriola acquires MedInfo ApS in Denmark to strengthen its Nordic footprint in medical information and patient support programmes | 1 | Cision News | ||
| 15:06 | Intuitive Surgical, Inc.: Intuitive Announces $45 Million Donation to the Intuitive Foundation to Promote Health and Advance Education | 5 | GlobeNewswire (USA) | ||
| 15:06 | These Analysts Revise Their Forecasts On HCA Healthcare Following Q4 Results | 2 | Benzinga.com | ||
| 15:06 | Alpha Tau Medical Ltd.: Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day | 1 | GlobeNewswire (USA) | ||
| 15:05 | Earnings Preview: What to Expect From Insulet's Report | 3 | Barchart.com |
Seite:
1 2 3 4 5 Weiter >>
- 24 h
- 7 Tage
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | Aktuelle Nachrichten | |||
|---|---|---|---|---|---|---|---|
| HVIVO | 6 | - | 0,00 % | ILiAD Biotechnologies, LLC: ILiAD and hVIVO Sign LOI for Pivotal Phase 3 Trial of BPZE1 Pertussis Vaccine Following FDA Meeting | Trial anticipated for H2 2025 to evaluate most advanced next generation intranasal pertussis vaccine for whooping cough
ILiAD Biotechnologies, LLC, a biotech company developing BPZE1, the most... ► Artikel lesen | ||
| HCA HEALTHCARE | 5 | 31 | -4,62 % | ROUNDUP: HCA Healthcare Q4 Beats Market, Sees Growth In FY25; Declares Dividend | WASHINGTON (dpa-AFX) - HCA Healthcare, Inc. (HCA), while reporting weak fourth-quarter profit, but above market estimates, on Friday issued fiscal 2025 outlook, higher than last year, and announced... ► Artikel lesen | ||
| PING AN HEALTHCARE | 5 | - | 0,00 % | PA GOODDOCTOR (01833): DISCLOSURE OF DEALINGS UNDER RULE 22 OF THE TAKEOVERS CODE | |||
| FRESENIUS MEDICAL CARE | 4 | 13 | +0,36 % | GOLDMAN SACHS stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Einstufung für FMC mit einem Kursziel von 52 Euro auf "Buy" belassen. Analyst Richard Felton nahm in einer am Montagabend vorliegenden... ► Artikel lesen | ||
| INTUITIVE SURGICAL | 4 | 10 | -2,07 % | Opening Bell: Bitcoin, Gold, Novo Nordisk, Oracle, Meta, Alphabet, Intuitive Surgical, Boeing | Per Videoschalte umriss Donald Trump gestern beim Wirtschaftstreffen in Davos sein Wirtschaftsprogramm. Dies sorgte für gute Stimmung an der Börse. Der Dow Jones legte 0,92 Prozent zu, der Nasdaq 100... ► Artikel lesen | ||
| VERU | 4 | - | -42,39 % | Veru Inc.: Veru Announces Positive Topline Data from Phase 2b QUALITY Clinical Study: Enobosarm Preserved Lean Mass in Patients Receiving WEGOVY (Semaglutide) for Weight Reduction | -- Study met primary endpoint: Enobosarm treatment resulted in statistically significant reduction in the loss of lean mass in subjects receiving WEGOVY (p=0.002) -- -- Patients on Enobosarm on average... ► Artikel lesen | ||
 | IHH HEALTHCARE | 3 | 4 | - | IHH HEALTHCARE BERHAD: GENERAL ANNOUNCEMENT::CHANGES IN SUBSTANTIAL SHAREHOLDER'S INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016 | ||
| INOGEN | 3 | - | +1,83 % | Arab Health 2025|Yuwell Medical Announces Strategic Investment and Partnership with Inogen in Respiratory Health | DUBAI, UAE, Jan. 27, 2025 /PRNewswire/ -- On the eve of the Arab Health Exhibition, Yuwell Medical held its 2025 Global Core Partner Conference in Dubai, and announced a strategic investment... ► Artikel lesen | ||
| ABINGDON HEALTH | 3 | - | - | Abingdon Health receives grant to develop malaria tests | |||
| STRAUMANN | 2 | 10 | +1,02 % | Straumann weiter mit US-Schwäche im dritten Quartal - China und EMEA stark | Basel - Straumann hat den Umsatz im dritten Quartal erneut gesteigert. Am jüngst erhöhten Ausblick hält der Hersteller von Dentalimplantaten fest. Straumann hat im Berichtsquartal 585,5 Millionen Franken... ► Artikel lesen |
- Alle
| Unternehmen / Aktien | Aktueller Kurs | Ø Kursziel (Euro) | Potential (Euro) | kaufen | halten | verkaufen | |||
|---|---|---|---|---|---|---|---|---|---|
| GERRESHEIMER AG | 66,05 | 109,94 | +66 % | 11 | 1 | - | |||
| STRATEC SE | 31,850 | 36,67 | +15 % | 2 | 4 | - | |||
| DRAEGERWERK AG & CO KGAA | 55,80 | 62,67 | +12 % | 8 | 2 | - | |||
| SIEMENS HEALTHINEERS AG | 53,74 | 59,99 | +12 % | 22 | 12 | - | |||
| FRESENIUS SE & CO KGAA | 36,970 | 40,86 | +11 % | 17 | 2 | - | |||
| ECKERT & ZIEGLER SE | 51,90 | 56,50 | +9 % | 4 | - | - | |||
| CARL ZEISS MEDITEC AG | 56,85 | 55,21 | -3 % | 4 | 11 | 8 | |||
| ESSILORLUXOTTICA SA | 256,90 | 236,60 | -8 % | 6 | 6 | - | |||
| FRESENIUS MEDICAL CARE AG | 46,820 | 40,03 | -14 % | 8 | 10 | 11 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
